GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $35,000 | 0.0% | 804 | 0.0% | 0.01% | +20.0% |
Q1 2022 | $35,000 | 0.0% | 804 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $35,000 | -7.9% | 804 | -19.9% | 0.01% | -16.7% |
Q3 2021 | $38,000 | -5.0% | 1,004 | 0.0% | 0.01% | -14.3% |
Q2 2021 | $40,000 | +37.9% | 1,004 | +24.9% | 0.01% | +40.0% |
Q1 2021 | $29,000 | -3.3% | 804 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $30,000 | -3.2% | 804 | -3.5% | 0.01% | 0.0% |
Q3 2020 | $31,000 | -6.1% | 833 | +3.6% | 0.01% | -25.0% |
Q2 2020 | $33,000 | +560.0% | 804 | +587.2% | 0.01% | +700.0% |
Q3 2019 | $5,000 | -44.4% | 117 | -49.1% | 0.00% | -66.7% |
Q3 2017 | $9,000 | -10.0% | 230 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $10,000 | 0.0% | 230 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $10,000 | +11.1% | 230 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $9,000 | -10.0% | 230 | 0.0% | 0.00% | -25.0% |
Q3 2016 | $10,000 | 0.0% | 230 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $10,000 | +11.1% | 230 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $9,000 | 0.0% | 230 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $9,000 | 0.0% | 230 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $9,000 | -10.0% | 230 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $10,000 | -37.5% | 230 | -33.5% | 0.00% | -42.9% |
Q1 2015 | $16,000 | +433.3% | 346 | +332.5% | 0.01% | +600.0% |
Q4 2014 | $3,000 | – | 80 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KAHN BROTHERS GROUP INC | 1,282,289 | $46,483,403 | 7.25% |
Columbia Asset Management | 9,960 | $361 | 0.08% |
PARK CIRCLE Co | 800 | $29,000 | 0.03% |
PARADIGM ASSET MANAGEMENT CO LLC | 1,800 | $65,250 | 0.02% |
Byrne Asset Management LLC | 56 | $2,000 | 0.00% |
Retirement Group, LLC | 40 | $1,450 | 0.00% |
Bartlett & Co. LLC | 240 | $9 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $40 | 0.00% |